SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 571 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $362,140 | +38.3% | 1,707 | +25.4% | 0.03% | +40.0% |
| Q2 2023 | $261,938 | +3.4% | 1,361 | +8.8% | 0.02% | 0.0% |
| Q1 2023 | $253,290 | +120.0% | 1,251 | +39.6% | 0.02% | +100.0% |
| Q4 2022 | $115,145 | -47.2% | 896 | -43.8% | 0.01% | -52.4% |
| Q3 2022 | $218,000 | -12.4% | 1,593 | +13.0% | 0.02% | -8.7% |
| Q2 2022 | $249,000 | +6.0% | 1,410 | -13.7% | 0.02% | +15.0% |
| Q1 2022 | $235,000 | +31.3% | 1,633 | +41.1% | 0.02% | +25.0% |
| Q4 2021 | $179,000 | -13.5% | 1,157 | -5.2% | 0.02% | -20.0% |
| Q3 2021 | $207,000 | +16.3% | 1,220 | +8.4% | 0.02% | +11.1% |
| Q2 2021 | $178,000 | +23.6% | 1,125 | +8.2% | 0.02% | +5.9% |
| Q1 2021 | $144,000 | +27.4% | 1,040 | +61.7% | 0.02% | 0.0% |
| Q4 2020 | $113,000 | +82.3% | 643 | +102.8% | 0.02% | +54.5% |
| Q3 2020 | $62,000 | – | 317 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |